Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Metis has launched a new high-performance chain, Hyperion, dedicated to AI. The test network will be launched before April this year

Metis has launched a new high-performance chain, Hyperion, dedicated to AI. The test network will be launched before April this year

Bitget2025/03/01 21:04

According to official news, the Metis Foundation's Natalia announced at ETH Denver that Metis is launching a new high-performance Layer 2 chain, Metis Hyperion. The new chain guarantees full compatibility with Ethereum while providing uncompromising security for AI applications, seamless scalability and enterprise-level system reliability. Its three key innovations include an optimized inference engine, accelerated hardware and zero-knowledge proofs which will enable AI models to run efficiently within blockchain infrastructure while maintaining high security.

Its testnet will be launched between February and April 2025, including high-performance sorting nodes, initial developer tools and framework testing functions. The mainnet will be delivered between May and August 2025, providing a high-throughput Layer 2 network and a complete developer suite in production environments. Between September and December of this year, the Metis Hyperion mainnet will undergo upgrades including instant feedback, parallel execution and enhanced support for AI models.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)

A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.

智通财经2026/08/29 02:27
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)